Product References
Semaglutide inhibits ischemia/reperfusion-induced cardiomyocyte apoptosis through activating PKG/PKCε/ERK1/2 pathway.
Biochemical and biophysical research communications
Zhu Q,Luo Y,Wen Y,Wang D,Li J,Fan Z
Sun Mar 05 00:00:00 EST 2023
Semaglutide inhibits ischemia/reperfusion-induced cardiomyocyte apoptosis through activating PKG/PKCε/ERK1/2 pathway.
Biochemical and biophysical research communications
Zhu Q,Luo Y,Wen Y,Wang D,Li J,Fan Z
Sun Mar 05 00:00:00 EST 2023
Semaglutide inhibits ischemia/reperfusion-induced cardiomyocyte apoptosis through activating PKG/PKCε/ERK1/2 pathway.
Biochemical and biophysical research communications
Zhu Q,Luo Y,Wen Y,Wang D,Li J,Fan Z
Sun Mar 05 00:00:00 EST 2023
Liraglutide Attenuates Myocardial Ischemia/Reperfusion Injury Through the Inhibition of Necroptosis by Activating GLP-1R/PI3K/Akt Pathway.
Cardiovascular toxicology
Zhou G,Wu H,Yang J,Ye M,Liu D,Li Y,Zhang D,Zhang J,Yang Q,Liu Y
Sat Apr 01 00:00:00 EDT 2023
Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120/ABHD6.
Drug design, development and therapy
Li R,Ye Z,She D,Fang P,Zong G,Hu K,Kong D,Xu W,Li L,Zhou Y,Zhang K,Xue Y
Mon Oct 17 00:00:00 EDT 2022
Neuroprotective effects of liraglutide against inflammation through the AMPK/NF-κB pathway in a mouse model of Parkinson's disease.
Metabolic brain disease
Cao B,Zhang Y,Chen J,Wu P,Dong Y,Wang Y
Tue Feb 01 00:00:00 EST 2022
Neuroprotective effects of liraglutide against inflammation through the AMPK/NF-κB pathway in a mouse model of Parkinson's disease.
Metabolic brain disease
Cao B,Zhang Y,Chen J,Wu P,Dong Y,Wang Y
Tue Feb 01 00:00:00 EST 2022
Clozapine Induced Disturbances in Hepatic Glucose Metabolism: The Potential Role of PGRMC1 Signaling.
Frontiers in endocrinology
Cao T,Chen Q,Zhang B,Wu X,Zeng C,Zhang S,Cai H
Mon Feb 14 00:00:00 EST 2022
A Potential Mechanism Underlying the Therapeutic Effects of Progesterone and Allopregnanolone on Ketamine-Induced Cognitive Deficits.
Frontiers in pharmacology
Cao T,Tang M,Jiang P,Zhang B,Wu X,Chen Q,Zeng C,Li N,Zhang S,Cai H
Sat Mar 27 00:00:00 EDT 2021
Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist S6 Stimulates Insulin Secretion From Rat Islets.
Frontiers in pharmacology
Yang X,Zhang M,Lu Z,Zhi L,Xue H,Liu T,Liu M,Cui L,Liu Z,He P,Liu Y,Zhang Y
Tue May 18 00:00:00 EDT 2021
Geniposide Improves Diabetic Nephropathy by Enhancing ULK1-Mediated Autophagy and Reducing Oxidative Stress through AMPK Activation.
International journal of molecular sciences
Dusabimana T,Park EJ,Je J,Jeong K,Yun SP,Kim HJ,Kim H,Park SW
Sat Feb 06 00:00:00 EST 2021
Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-κB and MAPK pathways via GLP-1R.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Li Z,Li S,Wang N,Xue P,Li Y
Thu Oct 01 00:00:00 EDT 2020
Liraglutide regulates proliferation, differentiation, and apoptosis of preosteoblasts through a signaling network of Notch/Wnt/Hedgehog signaling pathways.
European review for medical and pharmacological sciences
Hou HW,Xue P,Wang Y,Li YK
Tue Dec 01 00:00:00 EST 2020
Liraglutide inhibits the apoptosis of human nucleus pulposus cells induced by high glucose through PI3K/Akt/caspase-3 signaling pathway.
Bioscience reports
Ming-Yan Y,Jing Z,Shu-Qin G,Xiao-Liang B,Zhi-Hong L,Xue Z
Fri Aug 30 00:00:00 EDT 2019
Oxaliplatin reverses the GLP-1R-mediated promotion of intrahepatic cholangiocarcinoma by altering FoxO1 signaling.
Oncology letters
Chen B,Zhou W,Zhao W,Yuan P,Tang C,Wang G,Leng J,Ma J,Wang X,Hui Y,Wang Q
Thu Aug 01 00:00:00 EDT 2019
AWRK6, a Novel GLP-1 Receptor Agonist, Attenuates Diabetes by Stimulating Insulin Secretion.
International journal of molecular sciences
Wang Q,Zhao C,Jin L,Zhang H,Miao Q,Liu H,Zhang D
Sun Oct 07 00:00:00 EDT 2018
AWRK6, a Novel GLP-1 Receptor Agonist, Attenuates Diabetes by Stimulating Insulin Secretion.
International journal of molecular sciences
Wang Q,Zhao C,Jin L,Zhang H,Miao Q,Liu H,Zhang D
Sun Oct 07 00:00:00 EDT 2018